Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.77 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.77 |
| ▸ | THRB | P10828 | 4/20 | 0.77 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.77 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.77 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.77 |
| ▸ | PKM | P14618 | 1/20 | 0.77 |
| ▸ | HTT | P42858 | 3/20 | 0.62 |
| ▸ | LMNA | P02545 | 3/20 | 0.62 |
| ▸ | GAA | P10253 | 3/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.62 |
| ▸ | HPGD | P15428 | 2/20 | 0.62 |
| ▸ | RECQL | P46063 | 2/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.62 |
| ▸ | POLB | P06746 | 1/20 | 0.62 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29493005 | 1.00 | MAPT (0.77) | MAPTKDM4ETHRBSMN1; SMN2ALOX12 | |
| SCHEMBL4620865 | 0.88 | MAPT (0.78) | MAPTKDM4ETHRBSMN1; SMN2ALOX12 | |
| SCHEMBL3439007 | 0.88 | MAPT (0.77) | MAPTKDM4ETHRBSMN1; SMN2ALOX12 | |
| SCHEMBL14870331 | 0.88 | MAPT (0.77) | MAPTKDM4ETHRBSMN1; SMN2ALOX12 | |
| SCHEMBL9866595 | 0.87 | MAPT (0.58) | MAPTKDM4ETHRBSMN1; SMN2ALOX12 | |
| SCHEMBL23800830 | 0.87 | MAPT (0.58) | MAPTKDM4ETHRBSMN1; SMN2ALOX12 | |
| SCHEMBL3162588 | 0.87 | MAPT (0.58) | MAPTKDM4ETHRBSMN1; SMN2ALOX12 | |
| SCHEMBL13839771 | 0.87 | MAPT (1.00) | MAPTKDM4ETHRBSMN1; SMN2ALOX12 | |
| SCHEMBL80364 | 0.87 | MAPT (1.00) | MAPTKDM4ETHRBSMN1; SMN2ALOX12 | |
| SCHEMBL29493002 | 0.87 | MAPT (1.00) | MAPTKDM4ETHRBSMN1; SMN2ALOX12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11359136-B2 | Colorimetric indicators for photocurable sealants | THE BOEING COMPANY (US) | 2022-06-14 | — | — | US | claimed |
| US-9857882-B2 | Pointing display device | DONGWOO FINE-CHEM CO., LTD. (KR) | 2018-01-02 | — | — | US | claimed |
| US-20150079008-A1 | FLUORESCENCE PLAQUE-DISCLOSANT FOR DETECTING DENTAL PLAQUE | FLOSS MY HEART, LLC | 2015-03-19 | — | — | US | claimed |
| US-7033581-B2 | Method of treating hair with heat and a cap which provides a signal regarding treatment | UNILEVER HOME & PERSONAL CARE USA DIVISION OF CONOPCO, INC. (US) | 2006-04-25 | — | — | US | claimed |
| EP-1424918-B1 | METHOD OF TREATING HAIR WITH HEAT AND A CAP WHICH PROVIDES A SIGNAL REGARDING TREATMENT | UNILEVER PLC (GB) | 2005-11-23 | — | — | EP | claimed |
| US-20050074639-A1 | Method of treating hair with heat and a cap which provides a signal regarding treatment | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2005-04-07 | — | — | US | claimed |
| US-20030059459-A1 | Method of treating hair with heat and a cap which provides a signal regarding treatment | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2003-03-27 | — | — | US | claimed |
| US-20030030040-A1 | Reversibly variable photochromic color composition for articles composed of synthetic resin | LUTHERN JOHN JOSEPH (US) | 2003-02-13 | — | — | US | claimed |
| EP-0783130-B1 | Photochromic light meter | EASTMAN KODAK CO (US) | 2002-03-20 | — | — | EP | claimed |
| US-5747225-A | CAMERAS WITH SPIRONAPHTHOXAZINE DYES IN GELATIN LAYERS | EASTMAN KODAK COMPANY (US) | 1998-05-05 | — | — | US | claimed |
| EP-0783130-A1 | Photochromic light meter | EASTMAN KODAK COMPANY (US) | 1997-07-09 | — | — | EP | claimed |
| EP-4077464-B1 | FREE RADICAL POLYMERIZABLE ADHESION-PROMOTING INTERLAYER COMPOSITIONS AND METHODS OF USE | PRC DESOTO INT INC (US) | 2026-04-29 | — | — | EP | disclosed |
| US-12559593-B2 | Dual cure sealants | PRC-DESOTO INTERNATIONAL, INC. (CA) | 2026-02-24 | — | — | US | disclosed |
| US-20240199911-A1 | HYBRID DUAL CURE COMPOSITIONS | PRC-DESOTO INTERNATIONAL, INC. (US) | 2024-06-20 | — | — | US | disclosed |
| US-20240132752-A1 | COMPOSITIONS CONTAINING A FREE RADICAL POLYMERIZATION INITIATOR | PRC-DESOTO INTERNATIONAL, INC. (US) | 2024-04-25 | — | — | US | disclosed |
| US-5551973-A | LIQUID CRYSTAL GEL PHASE, MICROEMULSION PHASE | XEROX CORPORATION (US) | 1996-09-03 | — | — | US | disclosed |
| US-5431697-A | Reversibly variable color patterning composition for synthetic resin articles | MATSUI SHIKISO CHEMICAL CO., LTD. (JP) | 1995-07-11 | — | — | US | disclosed |
| US-5208132-A | Microencapsulation of hindered amines | MATSUI SHIKISO CHEMICAL CO., LTD. (JP) | 1993-05-04 | — | — | US | disclosed |
| EP-0480162-A1 | Dyeing method and dyed product | MATSUI SHIKISO CHEMICAL CO., LTD (JP) | 1992-04-15 | — | — | EP | disclosed |
| US-4756973-A | Three-dimensional network structure layer forming resin containing spirooxazine compound and phenolic resin | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1988-07-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559593-B2 | Dual cure sealants | DUOX2, DUOX1, GPX4 | MAPT 2965/4885KDM4E 518/4885THRB 2985/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.